Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
Ac-SIINFEKL-NH2
3D-Ansicht

Biosynth logo

Ac-SIINFEKL-NH2

Ref. 3D-PP45734

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 10. Dezember 2024

Produktinformation

Name:
Ac-SIINFEKL-NH2
Synonyme:
  • Ac-Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-amide
Beschreibung:

Peptide Ac-SIINFEKL-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-SIINFEKL-NH2 include the following: A supramolecular vaccine platform based on alpha-helical peptide nanofibers Y Wu , PK Norberg, EA Reap , KL Congdon - ACS biomaterials , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsbiomaterials.7b00561 Peptide-based cancer vaccine delivery via the STINGΔTM-cGAMP complex Y He , C Hong , SJ Fletcher, AG Berger - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202200905 Co-assembled and self-delivered epitope/CpG nanocomplex vaccine augments peptide immunogenicity for cancer immunotherapy X Shi, H Song, C Wang, C Zhang , P Huang - Chemical Engineering , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1385894720319823 Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific T Fifis, P Mottram, V Bogdanoska, J Hanley - Vaccine, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0400427X Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH SJ Crowley, PT Bruck, MA Bhuiyan - Open , 2020 - royalsocietypublishing.orghttps://royalsocietypublishing.org/doi/abs/10.1098/rsob.190235 of peptide-specific CTL activity and inhibition of tumor growth following immunization with nanoparticles coated with tumor peptide-MHC-I complexes SH Kim, HE Park, SU Jeong, JH Moon, YR Lee - Immune , 2021 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733191/ Development of a Stable Peptide-Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry SC Uslu , UJ Lee , S Tavakolpour - ACS Pharmacology & , 2024 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsptsci.3c00268 A modular antigen presenting peptide/oligonucleotide nanostructure platform for inducing potent immune response S Tohumeken , N Gunduz , MB Demircan - Advanced , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adbi.201700015 Well-Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity S Lv , K Song , A Yen , DJ Peeler - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202101651 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide P Cascio, C Hilton , AF Kisselev, KL Rock - The EMBO , 2001 - embopress.orghttps://www.embopress.org/doi/full/10.1093/emboj/20.10.2357 Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes NAW Lemmermann , K Gergely, V Böhm - Journal of , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02087-09 of IL-12 stimulates IFN-γ production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine ML Salem , AN Kadima, Y Zhou, CL Nguyen - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/9/5159/72120 Improvement of the enzymatic stability of a cytotoxic T-lymphocyte-epitope model peptide for its oral administration MK Marschutz, W Zauner, F Mattner, A Otava - Peptides, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978102001481 Tapasin enhances MHC class I peptide presentation according to peptide half-life M Howarth , A Williams, AB Tolstrup - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0306294101 Sortase-mediated modification of alphaDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes LK Swee, CP Guimaraes, S Sehrawat - Proceedings of the , 2013 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1214994110 Investigation of antigen delivery route in vivo and immune-boosting effects mediated by pH-sensitive liposomes encapsulated with Kb-restricted CTL epitope KY Lee, E Chun , BL Seong - Biochemical and biophysical research , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X02967112 In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles KS Kawamura, RC Su , LT Nguyen - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/11/5709/34240 Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL K Falk, O Rötzschke , S Faath, S Goth, I Graef - Cellular , 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712128 Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase J Beninga, KL Rock, AL Goldberg - Journal of Biological Chemistry, 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)80196-X/abstract 1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines I Rastogi , R Gibadullin , SH Gellman , D McNeel - 2023 - jitc.bmj.comhttps://jitc.bmj.com/content/11/Suppl_1/A1534.abstract A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway GA Pietersz, W Li, V Apostolopoulos - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0000373X Poly (propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines F Qiu , KW Becker , FC Knight, JJ Baljon , S Sevimli - Biomaterials, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S014296121830543X DUAL PEPTIDE CONJUGATES SIMULTANEOUSLY TRIGGERING TLR2 AND TLR7 FOR CANCER VACCINATION 5 E Tondini , TC van den Ende, MGM Camps, T Arakelian - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A3217809/download Anti-Peptide Antibody Blocks Peptide E Reticulum - J Immunol, 2001 - researchgate.nethttps://www.researchgate.net/profile/Craig-Hilton/publication/12092680_Anti-Peptide_Antibody_Blocks_Peptide_Binding_to_MHC_Class_I_Molecules_in_the_Endoplasmic_Reticulum/links/5de01809a6fdcc2837f3d244/Anti-Peptide-Antibody-Blocks-Peptide-Binding-to-MHC-Class-I-Molecules-in-the-Endoplasmic-Reticulum.pdf Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway DS Pouniotis, V Apostolopoulos , GA Pietersz - Immunology, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2005.02304.x Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma D Van Dinther , H Veninga, M Revet - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.01997/full Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer D Nobuoka, T Yoshikawa, M Takahashi - Cancer Immunology , 2013 - Springerhttps://link.springer.com/article/10.1007/s00262-012-1366-6 Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2) CL Nguyen, ML Salem , MP Rubinstein, M Demcheva - Vaccine, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X03000963 Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and CL Nguyen, JT Bui, M Demcheva - Journal of , 2001 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2001/09000/Sustained_Release_of_Granulocyte_Macrophage.4.aspx Anti-peptide antibody blocks peptide binding to MHC class I molecules in the endoplasmic reticulum CJ Hilton , AM Dahl, KL Rock - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/166/6/3952/70418 Anti-Peptide Antibody Blocks Peptide CJ Hilton , AM Dahl, KL Rock - scholar.archive.orghttps://scholar.archive.org/work/c72ogauyunfuhgex7k36gpd7w4/access/wayback/http://www.umassmed.edu/uploadedFiles/otm2/Ready_to_sign/00-32%20Ref.pdf Role of linker length and antigen density in nanoparticle peptide vaccine CH Kapadia , S Tian, JL Perry , JC Luft - ACS omega, 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.8b03391 Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines C Aguilar-Gurrieri , A Barajas, C Rovirosa - Cancer Immunology , 2023 - Springerhttps://link.springer.com/article/10.1007/s00262-023-03409-3 T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo AI Webb , MA Dunstone , NA Williamson - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/3810/73297 Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide A Craiu, T Akopian, A Goldberg - Proceedings of the , 1997 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.94.20.10850 Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis A Carambia, C Gottwick, D Schwinge, S Stein - , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imm.13298 N-hydroxy-amide analogues of MHC-class I peptide ligands with nanomolar binding affinities A Bianco , C Zabel, P Walden - of the European Peptide , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1099-1387(199812)4:8%3C471::AID-PSC166%3E3.0.CO;2-8 New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules A Bianco , C Brock, C Zabel, T Walk, P Walden - Journal of Biological , 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)59453-4/abstract

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP45734 Ac-SIINFEKL-NH2

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.